"In response to the need for mRNA COVID-19 vaccines during the pandemic ... and end-to-end RNA expertise under one roof, ...

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

The "North America RNA Therapeutics Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been ...

A critical challenge during the early COVID-19 pandemic was determining whether a patient would survive the infection or die ...

This year's headlines on COVID-19 featured new research on COVID-related mortality, post-acute sequelae of infection, vaccine ...

The study was conducted between 2021 and 2023, during the height of the COVID-19 global pandemic ... Prevention during the ...

Aligos Therapeutics, Inc. ( (ALGS) ) has released its Q3 earnings. Here is a breakdown of the information Aligos Therapeutics, Inc. presented ...

Arcturus Therapeutics ( (ARCT) ) has released its Q3 earnings. Here is a breakdown of the information Arcturus Therapeutics presented to its ...

Request To Download Free Sample of This Strategic Report @ The publisher has been closely monitoring the various markets in Saudi Arabia Peptide Therapeutics Market. This report provides a ...

Despite a dip in revenue, Arcturus Therapeutics Holdings Inc (ARCT) celebrates a successful vaccine launch in Japan and ...